Inhibition of pyruvate dehydrogenase kinase activity promotes apoptosis in colorectal cancer cells
B Madhok, S Yeluri, S Perry, TA Hughes, DG Jayne
The Leeds Teaching Hospitals NHS Trust, University of Leeds, Leeds, West Yorkshire, UK
Proffered paper presentation
Aims
Cancer
cells are highly dependent on glycolysis, the so-called Warburg effect, which
provides them with a competitive edge over normal cells. This study aimed to
determine if switching metabolism from glycolysis towards glucose oxidation
induces apoptosis preferentially in colorectal cancer cells over normal cells,
and to examine the underlying mechanisms.
Method
Cell
lines were treated with dichloroacetate, a non-specific inhibitor of pyruvate
dehydrogenase kinase (PDK) that promotes mitochondrial respiration. Assays were
performed to determine cell viability, apoptosis, cell-cycle profiles and
metabolic effects.
Results
Treatment
with dichloroacetate reduced cell viability in a dose-dependent fashion. 20 mM
dichloroacetate did not significantly reduce viability of the non-cancerous 293
cells, but caused a 30% decrease in cancer cell viability. The decreased
viability was due to a significant increase in proportion of apoptotic cells
and cells arrested in G2. The largest apoptotic effect was evident in the
metastatic LoVo cells. The mean percentage of apoptotic cells with no
dichloroacetate was 2 (95%CI: 0.9 to 3.1) compared to 23 (95%CI: 11.5 to 34.6)
with dichloroacetate. 293 cells were unaffected by dichloroacetate treatment:
0.6 (95%CI: -0.2 to 1.4) vs. 0.9 (95%CI: -0.1 to 1.7). Dichloroacetate
produced an 8-fold increase in the proportion of cancer cells in G2. To analyse
the alterations in metabolism, lactate levels and intrinsic mitochondrial
membrane potential (∆Ym) were measured. Dichloroacetate caused a 70%
reduction in lactate levels in both LoVo and 293 cells, suggesting that it
attenuates glycolysis. Dichloroacetate decreased ∆Ym in all cancer
cells, but not in 293 cells, indicating that it facilitates glucose oxidation
in cancer cells.
Conclusion
PDK
inhibition with dichloroacetate induces apoptosis in colorectal cancer cells,
possibly via the mitochondrial pathway. Further research to downregulate the
activity of the specific isoforms of PDK that are upregulated in cancer is
warranted.